Montair 4mg Chewable (Montelukast Sodium) – Affordable Singulair Alternative

Name: Montair 4mg Chewable
Brand: Singulair
SKU: 699
Availability: InStock

Montair 4 mg Chewable tablets contain Montelukast Sodium as the main active ingredient. Montelukast Sodium belongs to a category of drug known as leukotriene receptor antagonists. It is used for the maintenance treatment of asthma and other seasonal allergic symptoms. This drug can only treat the asthma symptoms like itchy, runny, or stuffy nose, and sneezing.

Montair Chewable 4mg tablets general information.

It is used to treat allergic symptoms such as itching, runny nose or watery eyes. This drug is a combination of antileukotriene and antihistamine drug, used in the allergic rhinitis condition.

How does Montair Chewable tablets works?

The active ingredient of Montair chewable tablets Montelukast, like Zafirlukast, is a leukotriene receptor antagonist used as an alternative to anti-inflammatory medications in the management and chronic treatment of asthma and exercise-induced bronchospasm (EIB). Unlike Zafirlukast, Montelukast does not inhibit CYP2C9 or CYP3A4 and is, therefore, not expected to affect the hepatic clearance of drugs metabolized by these enzymes.

Precautions

What medicines interact with Montair Chewable tablets?

It is important that you make known to your physician all the medications you use as there are several medicines which are found to interact with this drug are as follows:

Amodiaquine
Gemfibrozil
Lumacaftor
Loxapine
Tolbutamide

When should Montair Chewable tablets not be used?

You should avoid Montair Chewable tablets if you are:

If a patient is suffering from any kind of hepatic and renal problem, including dialysis treatment, mental disorder such as depression, this drug is harmful in these conditions, therefore, it is advised to consult your doctor and let him know about your medical history prior taking this drug.
Take this drug only when it is needed during pregnancy, it may harm the fetus therefore, it is advised to take this medicament under the doctor’s supervision with a regular checkup.
Do not drive or use any machinery because using these Tablets may have a minor or moderate effect on your ability to drive and using of machines. They may cause dizziness, so avoid driving and use of machines, while taking this drug
Avoid alcohol while taking this drug.
Use this drug with caution in elderly patients, older adults may be more sensitive to the side effects of this drug

Dosage Instructions

Side Effects

What are the side effects of Montair Chewable tablets?

There are several significant side effects of this drug that needs to be taken into consideration before taking the medicine:

Numbness
Tingling sensation
Itching
Swelling
Increased bleeding tendency
Churg-Strauss syndrome
Depression
Hallucinations
Anxiety
Sleeping problems
Severe dizziness
Rashes
Mood swings like agitation and aggression

How to Use

How should Montair Chewable tablets be used?

The medicine should be taken as prescribed by your physician. If possible, take the dose at a particular time each day; this will minimize the probability of a missed dose. Generally, 1 or two tablets are efficient to relieve you from the symptoms. Never overdose or under-dose, instead, take the prescribed dosage.

How long should you take Montair Chewable tablets?

The medicine should be taken for as long as the doctor has recommended. It should be consumed orally. It is advised to use this medication exactly as per your doctor’s instructions.

Missed dose of Montair Chewable tablets.

If you miss one dose of Montair Chewable tablets 4 mg, you should not attempt to double your next dose. Just do follow the regular dosing schedule.

How should Montair Chewable tablets be stored?

Montair Chewable tablets should be stored at controlled room temperature away from heat, moisture and temperature and in an airtight container. Keep it away from the reach of children and pets.

Infographics

FAQ

What is Montair 4mg Chewable Tablet used for?

Montair 4mg Chewable Tablet contains montelukast Sodiumium 4mg — the formulation for young children (aged 2–5 years). It is used for: prophylaxis and chronic treatment of asthma in children 2–5 years; perennial and seasonal allergic rhinitis in children 2–5 years. The chewable tablet formulation allows accurate dosing in children who cannot swallow standard tablets — the 4mg dose is specifically calibrated for this age group. Children aged 6–14 years use the 5mg chewable tablet. Montelukast in young children prevents leukotriene-driven airway inflammation that contributes to asthma exacerbations, particularly virus-triggered wheezing epiSodiumes that are common in this age group. Parents should be informed about the neuropsychiatric Boxed Warning (applicable at all ages) — monitoring for sleep disturbances, agitation, and behavioural changes is particularly important in young children who cannot verbalise mood changes.

How should Montair 4mg Chewable be given to young children?

Give Montair 4mg Chewable Tablet once daily in the evening. The tablet should be chewed thoroughly — not swallowed whole. Can be given with or without food. For children who struggle to chew: the tablet can be crushed and mixed with a small amount of food (check with pharmacist for approved food vehicles). Evening administration is preferred for asthma (reduces overnight inflammation during sleep when asthma is worst). Give every evening consistently — even on days when the child appears well. For allergic rhinitis: same once-daily evening dosing. The 4mg chewable contains phenylalanine (from aspartame) — patients with phenylketonuria (PKU) must be informed. Ensure the tablet is given to the child by a supervising adult — not left as a self-administered medication for young children.

Is Montair 4mg Chewable safe for children aged 2–5 years?

Montelukast 4mg chewable has been studied in children from age 2 years and is FDA-approved for this age group. Safety considerations in young children: the neuropsychiatric Boxed Warning applies — young children may manifest neuropsychiatric effects as sleep disturbances, unusual agitation, night terrors, nightmares, or unexplained irritability/aggression. Parents should be counselled to monitor and report these symptoms. Some paediatric guidelines now suggest reserving montelukast as second-line (after inhaled corticosteroids) due to the neuropsychiatric concern. Regular review (every 6 months) of whether the child still requires montelukast is recommended — some children with early childhood wheezing outgrow the need for controller therapy. Do not exceed 4mg/day for children under 6 years.

What drug interactions apply to Montair 4mg Chewable in children?

The same pharmacokinetic interaction profile applies as for adult montelukast — CYP3A4 and CYP2C8 pathways are relevant. In paediatric practice, the most relevant interactions: phenobarbitone (used as an antiepileptic in young children) is a CYP3A4 inducer that reduces montelukast levels — efficacy may be reduced; consider dose adjustment or alternative asthma controller. Phenytoin and carbamazepine (paediatric epilepsy medications): similarly reduce montelukast exposure. Corticosteroids: no pharmacokinetic interaction with inhaled corticosteroids — the combination is safe and is often used together. Antihistamines (cetirizine, loratadine): no pharmacokinetic interaction — commonly combined for allergic rhinitis in children. Aspirin and NSAIDs: aspirin-sensitive children should continue avoiding NSAIDs even on montelukast.

How does Montair 4mg Chewable compare to inhaled corticosteroids for preschool asthma?

In preschool children (2–5 years) with asthma, both montelukast 4mg and inhaled corticosteroids (ICS) are used as controller therapy. Evidence base: ICS are generally more effective at preventing exacerbations in children with persistent asthma symptoms. Montelukast advantages in this age group: oral administration avoids the technique and adherence challenges of inhaled therapy in 2–5 year-olds (spacers are needed for ICS, which some young children resist); effective for virus-triggered wheezing (the predominant asthma phenotype in preschool children); once-daily oral tablet is practically simpler than twice-daily inhaler. Current guidelines: trial of ICS or montelukast depending on asthma phenotype and practical considerations; for predominantly virus-triggered wheezing — montelukast or intermittent ICS; for persistent multi-trigger asthma — ICS is preferred with montelukast as an add-on.

Is Montair 4mg Chewable equivalent to Singulair 4mg Chewable?

Yes. Montair 4mg Chewable and branded Singulair 4mg Chewable both contain montelukast Sodiumium 4mg in equivalent chewable tablet formulations. Montair is the generic alternative providing the same paediatric leukotriene receptor antagonist therapy at significantly lower cost. PremiumRxDrugs.com stocks authentic manufacturer-sourced Montair 4mg Chewable verified for quality and bioequivalence.

Where can I buy Montair 4mg Chewable online?

Montair 4mg Chewable Tablets are available at PremiumRxDrugs.com, shipping to the USA, UK, Australia, and worldwide. Our licensed pharmacy provides authentic manufacturer-sourced paediatric montelukast at competitive prices. Free shipping on qualifying orders and discreet delivery make paediatric asthma and rhinitis treatment accessible internationally.

Can I order Montair 4mg Chewable from PremiumRxDrugs for international delivery?

Yes. PremiumRxDrugs.com ships Montair 4mg Chewable to the USA, UK, Australia, and many other countries. Our genuine manufacturer-verified paediatric montelukast tablets, competitive pricing, and free worldwide shipping on qualifying orders make us a reliable international pharmacy for young children's asthma treatment.

What side effects does Montair 4mg Chewable cause in children?

Common in young children: headache; irritability (may be medication-related or neuropsychiatric — monitor); GI effects (nausea, abdominal pain, diarrhoea — less common at 4mg than adult doses). Neuropsychiatric effects (Boxed Warning — applicable to all ages including young children): sleep disturbances (nightmares, night terrors, insomnia), unusual agitation or aggression, crying more than usual, fearfulness, and in older children — mood changes, depressive symptoms. Young children may be unable to verbalise these effects — parents must observe behavioural and sleep changes carefully. If any neuropsychiatric symptoms are suspected: stop montelukast and contact the prescribing doctor. The phenylalanine content (aspartame sweetener in chewable tablet): relevant only for children with PKU.

At what age can a child transition from Montair 4mg to 5mg Chewable?

Children transition from Montair 4mg Chewable (age 2–5 years) to Montair 5mg Chewable (age 6–14 years) when they reach 6 years of age. The dose increase from 4mg to 5mg reflects the pharmacokinetic maturation of the CYP enzyme systems and increasing body weight in school-age children. The transition is based on age rather than weight or symptom severity. At age 15 and above: transition to the adult Montair 10mg film-coated tablet. The prescriber should proactively update the prescription at each transition age. For children near the age transition: the previous formulation can continue until the next prescription review — a few extra weeks at the lower dose is not harmful. The once-daily evening dosing schedule remains the same across all age-appropriate formulations.

How should Montair 4mg Chewable be stored?

Store Montair 4mg Chewable at room temperature (15–30°C) away from direct sunlight, moisture, and heat. Do not store in the bathroom (humidity degrades tablets). Keep in the original foil blister packaging until just before use. Keep out of reach of children — despite being a children's medication, an unsupervised child could take multiple tablets; always administer under adult supervision. Check expiry date before use. Store in a cool, dry place such as a bedside cabinet or kitchen cupboard away from heat sources (stovetop, oven). If the tablet crumbles or changes appearance, replace with a fresh one from a new blister. Dispose of expired tablets responsibly — return to pharmacy.

Is Montair 4mg effective for virus-triggered wheezing in toddlers?

Montelukast 4mg is particularly useful for virus-triggered wheezing in 2-5 year-old children. Evidence shows montelukast 4mg reduces viral-triggered wheezing epiSodiumes, emergency visits, and oral corticosteroid courses in preschool children with atopic backgrounds (eczema, family history of asthma). Daily continuous montelukast is recommended for children with frequent epiSodiumes — intermittent use has not shown consistent benefit. Children with non-atopic purely viral wheeze may respond less well. Combining montelukast with a reliever bronchodilator (salbutamol) provides both background prevention and acute symptom relief. Reassess every 6 months whether controller therapy is still needed — some children outgrow preschool wheeze as their airway size increases with age.

SKU	699
Generic For	Singulair
Strength	4mg
Active Ingredient	Montelukast Sodium